AGT’s CEO to Present at NobleCon13

Filed Under: News Releases

View: 1.27.16 Press Release – NobleCon13

View: Noble Conference – Investor Presentation

View: Webcast

More AGT News Releases

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

The Cure Chronicles, an innovative video series launched by American Gene Technologies, is the winner of the third annual BioBuzz Media Award

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

Jeff Galvin, CEO and founder of American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has been awarded the Life Sciences Voice Top Industry Leaders Award

American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award

The AGT Pipeline

AGT Corporate Profile

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!

American Gene Technologies

24 hours ago

Kelly Schulz, CEO of Maryland Tech Council, speaks with Jeff Galvin, CEO of #AGT, about job opportunities within #Maryland’s #techindustry. Watch here. bit.ly/460tvaE ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

2 days ago

Our CEO Jeff Galvin is joining leaders from the global health community today at the Cantor Fitzgerald Global Healthcare Conference in #NYC to share our company’s vision for the future of #genetherapy. ... See MoreSee Less

Photo

View on Facebook

American Gene Technologies

3 days ago

Featured in @WBJOnline: #AGT welcomes Nick Tressler, MBA as Chief Financial Officer! Nick brings more than 20 years of experience maximizing stakeholder value as a strategic financial executive, enterprise leader, and operational business partner in the #life sciences, #biopharmaceutical, and #tech industries. Read more here. ... See MoreSee Less

Nick Tressler, MBA | People on The Move - Washington Business Journal

bit.ly

Nick Tressler, MBA Hired at Addimmune™ / American Gene Technologies®

View on Facebook

American Gene Technologies

5 days ago

#research is the cornerstone of progress. Innovative #Cancer research is the key to improving patient outcomes. #worldcancerresearch ... See MoreSee Less

Photo

View on Facebook

AGT’s CEO to Present at NobleCon13

More AGT News Releases

Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to Go Public Through Business Combination with 10X Capital Venture Acquisition Corp. III

American Gene Technologies® Launches New Spinoff Company “Addimmune™” to Focus Exclusively on Development of HIV Cure

American Gene Technologies® Video Series “The Cure Chronicles” Wins BioBuzz Media Award

American Gene Technologies® CEO Jeff Galvin Wins Life Sciences Voice Top Industry Leaders Award

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Investors

Pipeline

Technology

Media

About Us

More AGT News Releases

Follow AGT on Social Media

Subscribe to Press Release and News Updates

Get In Touch

American Gene Technologies Inc.

Contact Us

Sign-up For Our Newsletter